Some pharmacological characteristics of ganglionic activity of lobeline.
D000315:Adrenalectomy; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004147:Dioxins / Q000494:pharmacology; D004336:Drug Antagonism; D004353:Drug Evaluation, Preclinical; D005727:Ganglia, Spinal / Q000187:drug effects*; D005730:Ganglionic Blockers / Q000494:pharmacology; D005731:Ganglionic Stimulants / Q000494:pharmacology; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007275:Injections, Intravenous; D007679:Kidney Medulla / Q000187:drug effects; D008120:Lobeline / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine; D010879:Piperazines / Q000494:pharmacology; D014628:Vagotomy
D004147:Dioxins; D005730:Ganglionic Blockers; D005731:Ganglionic Stimulants; D006584:Hexamethonium Compounds; D010879:Piperazines; D004246:Dimethylphenylpiperazinium Iodide; D001285:Atropine; D008120:Lobeline; D009638:Norepinephrine